Halliday, Glenda M.
The University of Sydney
70 papers on CoChatORCID 0000-0003-0422-8398
Most cited papers
- Verified
Physiological changes in neurodegeneration—mechanistic insights and clinical utility
Ahmed, R. M., Ke, Y. D., Vucic, S., Ittner, L. M., Seeley, W., Hodges, J. R., Piguet, O., Halliday, G., & Kiernan, M. C. (2018) · Nature Reviews Neurology
Dementia and Cognitive Impairment ResearchAmyotrophic Lateral Sclerosis Research
Cited by 91
- Verified
Longitudinal white matter changes in frontotemporal dementia subtypes: Longitudinal White Matter Changes in FTD
Lam, B. Y. K., Halliday, G. M., Irish, M., Hodges, J. R., & Piguet, O. (2014) · Human Brain Mapping
Dementia and Cognitive Impairment ResearchAdvanced Neuroimaging Techniques and Applications
Cited by 90
- Verified
Altered lipid levels provide evidence for myelin dysfunction in multiple system atrophy
Don, A. S., Hsiao, J.-H. T., Bleasel, J. M., Couttas, T. A., Halliday, G. M., & Kim, W. S. (2014) · Acta Neuropathologica Communications
Parkinson's Disease Mechanisms and TreatmentsMultiple Sclerosis Research Studies
Cited by 88
- Verified
Neuropathologic assessment of participants in two multi‐center longitudinal observational studies: The Alzheimer Disease Neuroimaging Initiative (ADNI) and the Dominantly Inherited Alzheimer Network (DIAN)
Cairns, N. J., Perrin, R. J., Franklin, E. E., Carter, D., Vincent, B., Xie, M., Bateman, R. J., Benzinger, T., Friedrichsen, K., Brooks, W. S., et al. (2015) · Neuropathology
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 86
- Verified
Distribution of brain atrophy in behavioral variant frontotemporal dementia
Kril, J. J., Macdonald, V., Patel, S., Png, F., & Halliday, G. M. (2005) · Journal of the Neurological Sciences
Dementia and Cognitive Impairment ResearchAmyotrophic Lateral Sclerosis Research
Cited by 83
- Verified
Effect of Anti-inflammatory Medications on Neuropathological Findings in Alzheimer Disease
Halliday, G. M., Shepherd, C. E., McCann, H., Reid, W. G. J., Grayson, D. A., Broe, G. A., & Kril, J. J. (2000) · Archives of Neurology
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 72
- Verified · note
Progression in Behavioral Variant Frontotemporal Dementia: A Longitudinal Study
Devenney, E., Bartley, L., Hoon, C., O’Callaghan, C., Kumfor, F., Hornberger, M., Kwok, J. B., Halliday, G. M., Kiernan, M. C., Piguet, O., et al. (2015) · JAMA Neurology
Dementia and Cognitive Impairment ResearchAmyotrophic Lateral Sclerosis Research
Cited by 61
- Verified
Consensus neuropathological diagnosis of common dementia syndromes: testing and standardising the use of multiple diagnostic criteria
Halliday, G., Ng, T., Rodriguez, M., Harding, A., Blumbergs, P., Evans, W., Fabian, V., Fryer, J., Gonzales, M., Harper, C., et al. (2002) · Acta Neuropathologica
Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments
Cited by 57
- Verified
Disrupted myelin lipid metabolism differentiates frontotemporal dementia caused by GRN and C9orf72 gene mutations
Marian, O. C., Teo, J. D., Lee, J. Y., Song, H., Kwok, J. B., Landin-Romero, R., Halliday, G., & Don, A. S. (2023) · Acta Neuropathologica Communications
Amyotrophic Lateral Sclerosis ResearchLysosomal Storage Disorders Research
Cited by 50
- Verified
Biomarker discovery and development for frontotemporal dementia and amyotrophic lateral sclerosis
Katzeff, J. S., Bright, F., Phan, K., Kril, J. J., Ittner, L. M., Kassiou, M., Hodges, J. R., Piguet, O., Kiernan, M. C., Halliday, G. M., et al. (2022) · Brain
Amyotrophic Lateral Sclerosis ResearchDementia and Cognitive Impairment Research
Cited by 48
- Verified
Assessment of amyloid β in pathologically confirmed frontotemporal dementia syndromes
Tan, R. H., Kril, J. J., Yang, Y., Tom, N., Hodges, J. R., Villemagne, V. L., Rowe, C. C., Leyton, C. E., Kwok, J. B. J., Ittner, L. M., et al. (2017) · Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments
Cited by 48
- Verified
Cortical atrophy differentiates Richardson's syndrome from the parkinsonian form of progressive supranuclear palsy
Schofield, E. C., Hodges, J. R., Macdonald, V., Cordato, N. J., Kril, J. J., & Halliday, G. M. (2011) · Movement Disorders
Parkinson's Disease Mechanisms and TreatmentsDementia and Cognitive Impairment Research
Cited by 48
- Verified
Evaluation of plasma levels of NFL, GFAP, UCHL1 and tau as Parkinson's disease biomarkers using multiplexed single molecule counting
Youssef, P., Hughes, L., Kim, W. S., Halliday, G. M., Lewis, S. J. G., Cooper, A., & Dzamko, N. (2023) · Scientific Reports
Parkinson's Disease Mechanisms and TreatmentsDementia and Cognitive Impairment Research
Cited by 46
- Verified
Clinical and biological correlates of white matter hyperintensities in patients with behavioral-variant frontotemporal dementia and Alzheimer disease
Huynh, K., Piguet, O., Kwok, J., Dobson-Stone, C., Halliday, G. M., Hodges, J. R., & Landin-Romero, R. (2021) · Neurology
Dementia and Cognitive Impairment ResearchCerebrovascular and genetic disorders
Cited by 43
- Verified
Increased ATP-binding cassette transporter A1 expression in Alzheimer's disease hippocampal neurons
Kim, W. S., Bhatia, S., Elliott, D. A., Agholme, L., Kågedal, K., McCann, H., Halliday, G. M., Barnham, K. J., & Garner, B. (2010) · Journal of Alzheimer's Disease
Alzheimer's disease research and treatmentsDrug Transport and Resistance Mechanisms
Cited by 40
- Verified
Predictors of survival and progression in behavioural variant frontotemporal dementia
Agarwal, S., Ahmed, R. M., D'Mello, M., Foxe, D., Kaizik, C., Kiernan, M. C., Halliday, G. M., Piguet, O., & Hodges, J. R. (2019) · European Journal of Neurology
Dementia and Cognitive Impairment ResearchAmyotrophic Lateral Sclerosis Research
Cited by 31
- Verified
Prion-like α-synuclein pathology in the brain of infants with Krabbe disease
Hatton, C., Ghanem, S. S., Koss, D. J., Abdi, I. Y., Gibbons, E., Guerreiro, R., Bras, J., International DLB Genetics Consortium, Bras, J., Guerreiro, R., et al. (2022) · Brain
Lysosomal Storage Disorders ResearchParkinson's Disease Mechanisms and Treatments
Cited by 28
- Verified
Reproducible sampling regimen for specific cortical regions: application to speech-associated areas
Harasty, J., Halliday, G. M., & Kril, J. J. (1996) · Journal of Neuroscience Methods
Classical Anatomy and HistologyAnatomy and Medical Technology
Cited by 23
- Verified
Aspects of innate immunity and Parkinson's disease
Huang, Y., & Halliday, G. M. (2012) · Frontiers in Pharmacology
Parkinson's Disease Mechanisms and TreatmentsNeuroinflammation and Neurodegeneration Mechanisms
Cited by 22
- Verified
Animal modeling an oligodendrogliopathy – multiple system atrophy
Bleasel, J. M., Halliday, G. M., & Kim, W. S. (2016) · Acta Neuropathologica Communications
Parkinson's Disease Mechanisms and TreatmentsNeuroinflammation and Neurodegeneration Mechanisms
Cited by 19
- Verified
VISA—A pass to innate immunity
Qi, B., Huang, Y., Rowe, D., & Halliday, G. (2007) · The International Journal of Biochemistry & Cell Biology
interferon and immune responsesNF-κB Signaling Pathways
Cited by 18
- Verified
Alzheimer's amyloid‐β and tau protein accumulation is associated with decreased expression of the LDL receptor‐associated protein in human brain tissue
Shepherd, C. E., Affleck, A. J., Bahar, A. Y., Carew‐Jones, F., Gregory, G., Small, D. H., & Halliday, G. M. (2020) · Brain and Behavior
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 11
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free